DCF — PRESBYTERIAN ST. LUKES MEDICAL CENT
Enterprise Value: $411.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$411.7M
Enterprise Value
$104.8M
PV of Cash Flows
$306.9M
PV of Terminal Value
$494.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $665.4M | $56.6M | 8.0% | $18.4M | $16.7M |
| Year 2 | $685.4M | $65.1M | 9.0% | $24.1M | $19.9M |
| Year 3 | $705.9M | $74.1M | 10.0% | $30.1M | $22.6M |
| Year 4 | $727.1M | $80.0M | 11.0% | $33.8M | $23.1M |
| Year 5 | $748.9M | $84.3M | 11.0% | $36.2M | $22.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $411.7M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$646.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999931890547
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5